Evidence map›Paper›PMID 31074257›Full record

ArticleACS applied materials & interfaces2019

Assessment of Copper Nanoclusters for Accurate in Vivo Tumor Imaging and Potential for Translation.

Gyu Seong Heo, Yongfeng Zhao, Deborah Sultan, Xiaohui Zhang, Lisa Detering, Hannah P Luehmann, Xiangyu Zhang, Richen Li, Ankur Choksi, Savannah Sharp and 10 more

Open access · greenAbstract read
In one paragraph

Article in ACS applied materials & interfaces, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
3.1field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 48 citations in OpenAlex.

  1. Review
  2. Nanoparticle-Mediated Immunotherapy in Triple-Negative Breast Cancer.ACS biomaterials science & engineering · 2024
    Review
  3. The Role of Cuproptosis Key Factor FDX1 in Gastric Cancer.Current pharmaceutical biotechnology · 2024
    Article
  4. Article
  5. Article
  6. Review
  7. Functionalized nanoparticles targeting biomarkers for prostate cancer imaging and therapy.American journal of clinical and experimental urology · 2022
    Review
  8. Review
  9. Article
  10. Article
  11. A review of advances in the last decade on targeted cancer therapy usingAmerican journal of nuclear medicine and molecular imaging · 2021
    Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Purification and separation of ultra-small metal nanoclusters.Advances in colloid and interface science · 2020
    Review
  17. Review
  18. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors at 6 institutions in 1 country.

Gyu Seong HeoMallinckrodt Institute of Radiology , Washington University , St. Louis , Missouri 63110 , United States.
Yongfeng ZhaoDepartment of Chemistry and Biochemistry , Jackson State University , Jackson , Mississippi 39217 , United States.ORCID http://orcid.org/0000-0003-2962-7504
Deborah SultanMallinckrodt Institute of Radiology , Washington University , St. Louis , Missouri 63110 , United States.
Xiaohui ZhangMallinckrodt Institute of Radiology , Washington University , St. Louis , Missouri 63110 , United States.
Lisa DeteringMallinckrodt Institute of Radiology , Washington University , St. Louis , Missouri 63110 , United States.
Hannah P LuehmannMallinckrodt Institute of Radiology , Washington University , St. Louis , Missouri 63110 , United States.
Xiangyu ZhangDepartment of Medicine , Washington University , St. Louis , Missouri 63110 , United States.
Richen LiMallinckrodt Institute of Radiology , Washington University , St. Louis , Missouri 63110 , United States.
Ankur ChoksiUniversity of Maryland School of Medicine , Baltimore , Maryland 21201 , United States.
Savannah SharpNew York University , New York , New York 10003 , United States.
Sidney LevingstonMallinckrodt Institute of Radiology , Washington University , St. Louis , Missouri 63110 , United States.
Tina PrimeauDepartment of Medicine , Washington University , St. Louis , Missouri 63110 , United States.
David E ReichertMallinckrodt Institute of Radiology , Washington University , St. Louis , Missouri 63110 , United States.ORCID http://orcid.org/0000-0003-3432-8998
Guorong SunMallinckrodt Institute of Radiology , Washington University , St. Louis , Missouri 63110 , United States.
Babak RazaniDepartment of Medicine , Washington University , St. Louis , Missouri 63110 , United States.
Shunqiang LiDepartment of Medicine , Washington University , St. Louis , Missouri 63110 , United States.
Katherine N WeilbaecherDepartment of Medicine , Washington University , St. Louis , Missouri 63110 , United States.
Farrokh DehdashtiMallinckrodt Institute of Radiology , Washington University , St. Louis , Missouri 63110 , United States.
Karen L WooleyDepartment of Chemistry, Department of Chemical Engineering, Department of Materials Science & Engineering, and Laboratory for Synthetic-Biologic Interactions , Texas A&M University , College Station , Texas 77842 , United States.
Yongjian LiuMallinckrodt Institute of Radiology , Washington University , St. Louis , Missouri 63110 , United States.ORCID http://orcid.org/0000-0002-1118-1535
Mallinckrodt (United States) · USWashington University in St. Louis · USJackson State University · USNew York University · USTexas A&M University · USUniversity of Maryland, Baltimore · US

Funding

TrainingP41GM103422 · NIGMS · WASHINGTON UNIVERSITY · PI ROHRS, HENRY W · 2012 to 2019
$12.0M
WASHINGTON UNIVERSITY CO-CLINICAL IMAGING RESEARCH RESOURCEU24CA209837 · NCI · WASHINGTON UNIVERSITY · PI Li Ding, Shunqiang Li · 2017 to 2026
$6.3M
THE ROLE OF MACROPHAGE LYSOSOMAL BIOGENESIS IN ATHEROSCLEROSISR01HL125838 · NHLBI · WASHINGTON UNIVERSITY · PI RAZANI, BABAK · 2015 to 2025
$4.6M
Expanding Access to Planar Illumination Microscopy in a Neuroimaging CoreR24NS086741 · NINDS · WASHINGTON UNIVERSITY · PI TAGHERT, PAUL H · 2014 to 2017
$814k
Harnessing the Autophagy-Lysosomal Biogenesis Response in Macrophages to Treat AtherosclerosisI01BX003415 · VA · VETERANS HEALTH ADMINISTRATION · PI RAZANI, BABAK · 2018 to 2025
–
BLRD VA I01 BX003415NCI NIH HHS U24 CA209837NHLBI NIH HHS R01 HL125838NIGMS NIH HHS P41 GM103422NINDS NIH HHS R24 NS086741
6 · The paper itself

Abstract

Nanoparticles have been widely used for preclinical cancer imaging. However, their successful clinical translation is largely hampered by potential toxicity, unsatisfactory detection of malignancy at early stages, inaccurate diagnosis of tumor biomarkers, and histology for imaging-guided treatment. Herein, a targeted copper nanocluster (CuNC) is reported with high potential to address these challenges for future translation. Its ultrasmall structure enables efficient renal/bowel clearance, minimized off-target effects in nontargeted organs, and low nonspecific tumor retention. The pH-dependent in vivo dissolution of CuNCs affords minimal toxicity and potentially selective drug delivery to tumors. The intrinsic radiolabeling through the direct addition of

Indexed as

AnimalsBreast NeoplasmsCopperCopper RadioisotopesDrug CarriersFemaleHumansMiceNanoparticlesPeptides, CyclicPositron-Emission TomographyReceptors, CXCR4Triple Negative Breast NeoplasmsCopperCopper RadioisotopesCXCR4 protein, humanCXCR4 protein, mousecyclo(tyrosyl-arginyl-arginyl-3-(2-naphthyl)alanyl-glycyl)Drug CarriersPeptides, CyclicReceptors, CXCR4breast cancercopper nanoclusterCXCR4positron emission tomographytranslation

Identifiers

PMID31074257
PMCPMC7811435
OpenAlexW2944013591

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.